HOME › DRUGS › RIVASTIGMINE TARTRATE
ACTIVE SUBSTANCE / INN

RIVASTIGMINE TARTRATE

Brand name(s): EXELON, RIVASTIGMINE TARTRATE, RIVASTIGMINE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA077363
ANDA204572
ACTIVE SUBSTANCE
Rivastigmine Tartrate
REGULATORS
FDA
SPONSORS / MAH
NOVARTIS, RANBAXY, AUROBINDO PHARMA
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RIVASTIGMINE TARTRATEANDA204572AUROBINDO PHARMAPrescription
RIVASTIGMINE TARTRATEANDA077131SUN PHARMDiscontinued
RIVASTIGMINEANDA077363RANBAXYNone (Tentative Approval)
EXELONNDA020823NOVARTISDiscontinued

FULL INTELLIGENCE ON RIVASTIGMINE TARTRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →